Evofem Bio's Amphora Fast Track'd for prevention of chlamydia in women [Seeking Alpha]
Evofem Biosciences, Inc. (EVFM)
Last evofem biosciences, inc. earnings: 3/12 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
evofem.com
Company Research
Source: Seeking Alpha
Evofem Bio's Amphora Fast Track'd for prevention of chlamydia in womenThe FDA hasdesignated Evofem Biosciences' (NASDAQ:EVFM) Amphora (L-lactic acid, citric acid and potassium bitartrate) vaginal gel for Fast Track review for the prevention of urogenital chlamydia in women.Fast Track status provides for more frequent interactions with the FDA review team and a rolling review of the marketing application.A Phase 2b/3 study assessing Amphora for the indication is underway. A Phase 3 trial evaluating Amphora for the prevention of pregnancy is also in process.Shares are up9% premarket but only on 100 shares.See all stocks on the move »Now read:Your Daily Pharma Scoop: Portola Still Attractive, Johnson & Johnson Reports Q4 Results, Cerus Reports Positive Results »
Show less
Read more
Impact Snapshot
Event Time:
EVFM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EVFM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EVFM alerts
High impacting Evofem Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
EVFM
Sec Filings
- 3/28/24 - Form 8-K
- 3/27/24 - Form 10-K
- 3/27/24 - Form 8-K
- EVFM's page on the SEC website